Bryan r luce (25 résultats)

Etat : Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

23,5 x 15,5 cm. Etat : Gut. XVIII, 318 Seiten Principles, Practice, and Potential. - Innen sauberer, guter Zustand. Leineneinband, mit den üblichen Bibliotheks-Markierungen, Stempeln und Einträgen, innen wie außen, siehe Bilder. (Evtl. auch Kleber- und/oder Etikettenreste, sowie -abdrücke durch abgelöste Bibliotheksschilder). DE-50-03 Sprache: Englisch Gewicht in Gramm: 650.…

Etat : New.

Etat : New.

Etat : New. In English.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide.…

Etat : As New. Unread book in perfect condition.

Etat : New. pp. xv + 184.

Paperback. Etat : Brand New. reprint edition. 199 pages. 9.50x6.70x0.60 inches. In Stock.

Etat : New.

Etat : New. In English.

Etat : As New. Unread book in perfect condition.

Hardback. Etat : New. This book presents an international perspective on health care technology and its development providing fully up-to-date coverage of this most rapidly developing area. This is the only comprehensive review of the subject available. Thoroughly referenced it deals with all types of health technologies - drugs, devices, and procedures and combines cost and other socio-economic analyses with information on diffusion, dissemination and use, as well as efficacy and safety testing. For all those faced with decisions concerning health care technology, this is an unrivalled guide.…

Etat : gut. 1982. Cost-Benefit and Cost-Effectiveness Analysis in Health Care In englischer Sprache. pages.

Paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardback. Etat : New. This book presents an international perspective on health care technology and its development providing fully up-to-date coverage of this most rapidly developing area. This is the only comprehensive review of the subject available. Thoroughly referenced it deals with all types of health technologies - drugs, devices, and procedures and combines cost and other socio-economic analyses with information on diffusion, dissemination and use, as well as efficacy and safety testing. For all those faced with decisions concerning health care technology, this is an unrivalled guide.…

Etat : As New. Unread book in perfect condition.

Etat : new. Questo è un articolo print on demand.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide. 204 pp. Englisch.…

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers . …

HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 204 pp. Englisch.…

Etat : New. Print on Demand pp. xv + 184 17 Figures.

Etat : New. PRINT ON DEMAND pp. xv + 184.

Hardcover. Etat : new. Hardcover. This book presents an international perspective on health care technology and its development providing fully up-to-date coverage of this most rapidly developing area. This is the only comprehensive review of the subject available. Thoroughly referenced it deals with all types of health technologies - drugs, devices, and procedures and combines cost and other socio-economic analyses with information on diffusion, dissemination and use, as well as efficacy andsafety testing. For all those faced with decisions concerning health care technology, this is an unrivalled guide. This volume examines the method of technology assessment for evaluating health care technology and its implications. A growing number of countries are now using this technique in health care as a help to policy-makers, clinicians and patients in making difficult choices. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…